This cohort study analyzes data for children from the population-based study Growing Up in Singapore Toward Healthy Outcomes (GUSTO) to examine the associations
Phase II of Singapore s National Precision Medicine strategy to begin in April 2021
Precision medicine is part of Singapore s Research, Innovation and Enterprise (RIE) 2025 strategic goal to transform and protect the health of every Singaporean. Identified as a priority by the Ministry of Health, precision medicine aims to understand how genomic, phenotypic, lifestyle and clinical factors contribute to the health of Singaporeans. It also supports the responsible use of health data in clinical applications with the longer-term goal of addressing Singapore s healthcare challenges in a sustainable and clinically cost-effective manner.
Singapore s National Precision Medicine (NPM) strategy is a 10-year plan to enhance and accelerate Singapore s biomedical research, health outcomes and economic growth. NPM is a whole-of-government effort to establish the necessary frameworks and infrastructure to realise precision medicine on a national scale, to ultimately improve public health, enhanc
Singapore launches next phase of National Precision Medicine Programme
New national body established to further research insights, improve patient outcomes and create new economic opportunities for the biomedical technology industry.
Precision Health Research, Singapore
SINGAPORE, 7 April 2021 – Precision medicine is part of Singapore’s Research, Innovation and Enterprise (RIE) 2025 strategic goal to transform and protect the health of every Singaporean. Identified as a priority by the Ministry of Health, precision medicine aims to understand how genomic, phenotypic, lifestyle and clinical factors contribute to the health of Singaporeans. It also supports the responsible use of health data in clinical applications with the longer-term goal of addressing Singapore’s healthcare challenges in a sustainable and clinically cost-effective manner.